QuantHealth raises $45M series B to accelerate AI-driven clinical trial simulations

QuantHealth, which uses artificial intelligence to develop clinical trial designs, secured $45 million in series B funding to accelerate adoption of its simulation-first clinical trial development | The company plans to use the fresh capital to advance its R&D, grow its team and expand its product portfolio, CEO and co-founder Orr Inbar told Fierce Healthcare.